Andere talen Talphera, Inc.

Aandelen

TLPH

US00444T2096

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1 ^USD	-2,91%		+3,09%	+36,05%

06/03	Talphera, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
06/03	Transcript : Talphera, Inc., Q4 2023 Earnings Call, Mar 06, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Talphera: Q4 Earnings Snapshot	06/03
Talphera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members	04/03
Talphera, Inc. Announces Management Changes	01/03
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members	01/03
Talphera, Inc. Appoints Abhinav Jain to Serve as a Class II Director	22/01
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA Acquisition	19/01
XOMA Acquires Interest in Pain Management Medication Dsuvia for $8 Million	18/01
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering	18/01
XOMA Corporation acquired DSUVIA® of Talphera, Inc. for $8 million.	18/01
Talphera, Inc. announced that it expects to receive $16 million in funding from Nantahala Capital Management, LLC, Rosalind Advisors, Inc.	17/01
AcelRx Pharmaceuticals, Inc. will Change its Ticker to TLPH from ACRX	10/01
AcelRx Announces Rebranding With Name Change to Talphera, Inc.	09/01
Talphera Expects to Initiate the Registrational Study of Niyad	09/01
Talphera, Inc.(NasdaqGM:TLPH) dropped from NASDAQ Composite Index	09/01
AcelRx Pharmaceuticals, Inc. has Changed its Name to Talphera, Inc	09/01
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States	12/12
AcelRx Pharmaceuticals: Q3 Earnings Snapshot	08/11
AcelRx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2023	08/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Talphera, Inc.

Aandelen

TLPH

US00444T2096

Andere talen

Filters